Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
174 participants
OBSERVATIONAL
2017-09-15
2020-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Human Milk Composition in Indian Mothers
NCT03061929
Lipids and Other Bioactive Compounds of Human Breast Milk
NCT03746886
Breast Milk Composition: Interindividual Variations and Dietary Factors in Galicia
NCT03245697
Investigation of the Effect of Mother's Nutrition Status on Breast Milk Contents
NCT04158999
A Study in Lactating Mothers and Their Newborns to Analyse the Composition of Human Milk
NCT05979532
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In the second part the investigators aim to evaluate the circadian variation of human milk macronutrient and energy content depending on pregnancy duration.
In the third part the investigators aim to evaluate the influence of Holder pasteurisation on human milk macronutrient, metabolome and bioactive protein (lysozyme and lactoferrin) content.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mothers of extremely preterm infants
(gestational age \< 28 weeks)
Analysis of human milk composition by mid-infrared spectrophotometry
Analysis of human milk macronutrient content was performed by mid-infrared spectrophotometry using a Miris Human Milk Analyser.
An immune-enzymatic ELISA assays were used to estimate lysozyme and lactoferrin concentrations in human milk.
Mothers of very preterm infants
(gestational age 28 - 31 weeks)
Analysis of human milk composition by mid-infrared spectrophotometry
Analysis of human milk macronutrient content was performed by mid-infrared spectrophotometry using a Miris Human Milk Analyser.
An immune-enzymatic ELISA assays were used to estimate lysozyme and lactoferrin concentrations in human milk.
Mothers of moderate and late preterm infants
(gestational age 32 - 36 weeks)
Analysis of human milk composition by mid-infrared spectrophotometry
Analysis of human milk macronutrient content was performed by mid-infrared spectrophotometry using a Miris Human Milk Analyser.
An immune-enzymatic ELISA assays were used to estimate lysozyme and lactoferrin concentrations in human milk.
Mothers of term infants
(gestational age ≥ 37 weeks)
Analysis of human milk composition by mid-infrared spectrophotometry
Analysis of human milk macronutrient content was performed by mid-infrared spectrophotometry using a Miris Human Milk Analyser.
An immune-enzymatic ELISA assays were used to estimate lysozyme and lactoferrin concentrations in human milk.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Analysis of human milk composition by mid-infrared spectrophotometry
Analysis of human milk macronutrient content was performed by mid-infrared spectrophotometry using a Miris Human Milk Analyser.
An immune-enzymatic ELISA assays were used to estimate lysozyme and lactoferrin concentrations in human milk.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
\-
Exclusion Criteria
\-
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Cagliari
OTHER
Vilnius University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Vytautas Usonis, MD
Role: STUDY_DIRECTOR
Vilnius University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Neonatal centre of Vilnius University Hospital Santaros Klinikos
Vilnius, , Lithuania
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Paulaviciene IJ, Liubsys A, Eidukaite A, Molyte A, Tamuliene L, Usonis V. The Effect of Prolonged Freezing and Holder Pasteurization on the Macronutrient and Bioactive Protein Compositions of Human Milk. Breastfeed Med. 2020 Sep;15(9):583-588. doi: 10.1089/bfm.2020.0219. Epub 2020 Aug 26.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MPS-2017
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.